XTX Topco Ltd Purchases Shares of 10,836 Harrow, Inc. (NASDAQ:HROW)

XTX Topco Ltd acquired a new position in Harrow, Inc. (NASDAQ:HROW) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,836 shares of the company’s stock, valued at approximately $487,000.

A number of other hedge funds have also recently made changes to their positions in the business. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Harrow by 21.5% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,283 shares of the company’s stock valued at $57,000 after acquiring an additional 227 shares during the period. The Manufacturers Life Insurance Company lifted its position in Harrow by 5.0% in the second quarter. The Manufacturers Life Insurance Company now owns 11,865 shares of the company’s stock valued at $248,000 after purchasing an additional 567 shares during the last quarter. Quest Partners LLC bought a new position in shares of Harrow in the third quarter worth approximately $29,000. Price T Rowe Associates Inc. MD increased its stake in shares of Harrow by 6.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 16,672 shares of the company’s stock worth $221,000 after buying an additional 1,033 shares during the period. Finally, nVerses Capital LLC bought a new stake in Harrow during the 2nd quarter valued at $33,000. 72.76% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HROW has been the topic of a number of recent analyst reports. Craig Hallum raised their price target on shares of Harrow from $45.00 to $65.00 and gave the stock a “buy” rating in a report on Friday, October 4th. B. Riley cut their target price on Harrow from $73.00 to $69.00 and set a “buy” rating on the stock in a research note on Wednesday, December 4th. Finally, Lake Street Capital upped their price target on Harrow from $45.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, October 4th.

Harrow Stock Down 2.5 %

Shares of Harrow stock opened at $35.50 on Friday. The company has a current ratio of 1.55, a quick ratio of 1.44 and a debt-to-equity ratio of 3.23. Harrow, Inc. has a 12-month low of $9.13 and a 12-month high of $59.23. The company has a market cap of $1.26 billion, a P/E ratio of -37.77 and a beta of 0.69. The company’s fifty day simple moving average is $46.12 and its two-hundred day simple moving average is $36.05.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.